NCT00002261
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +14 more
- Locations
-
- Bristol - Myers Squibb Co Wallingford, Connecticut, United States
Clinical trial condition
Poxviridae Infections
Explore clinical trials studying Poxviridae Infections. Study availability and eligibility vary by location and protocol.
164 public trials
17 recruiting studies
Poxviridae Infections trial results
Completed
Safety and Immunogenicity of CJ-50300
NCT00336635
- Conditions
- DNA Virus Infections, Infections, Poxviridae Infections, +2 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
NCT00189969
- Conditions
- DNA Virus Infections, Infections, Poxviridae Infections, +2 more
- Locations
-
- Focus Clinical Drug Development GmbH Neuss, Nordrhein, Germany
Completed
Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy Subjects
NCT00189943
- Conditions
- DNA Virus Infections, Infections, Poxviridae Infections, +2 more
- Locations
-
- PharmPlanNet Contract Research GmbH Mönchengladbach, Germany
NCT07499739
- Conditions
- Animal Diseases, DNA Virus Infections, Infections, +6 more
- Locations
-
- Centre Convivial Kasa-Vubu Kinshasa, Democratic Republic of the Congo
- Kinoise Kinshasa, Democratic Republic of the Congo
- Kokolo Kinshasa, Democratic Republic of the Congo
Active, Not Recruiting
Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease
NCT05597735
- Conditions
- Animal Diseases, DNA Virus Infections, Infections, +7 more
- Locations
-
- Fundación Huésped Buenos Aires, Argentina
- Faculty of Medicine, Federal University of Minas Gerais Belo Horizonte, Brazil
- Evandro Chagas National Institute of Infectious Diseases-Oswaldo Cruz Foundation-FIOCRUZ Rio de Janeiro, Brazil
- Federal Hospital for State Employees Rio de Janeiro, Brazil
Active, Not Recruiting
An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC
NCT06839989
- Conditions
- Animal Diseases, DNA Virus Infections, Infections, +6 more
- Locations
-
- Centre Hospitalier Kabinda Kinshasa, Democratic Republic of the Congo
Active, Not Recruiting
Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC
NCT06844487
- Conditions
- Animal Diseases, Children, DNA Virus Infections, +12 more
- Locations
-
- Boende Hôpital Général de Référence, Boende Boende, La Tshuapa, Democratic Republic of the Congo
Active, Not Recruiting
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
NCT07199569
- Conditions
- Animal Diseases, DNA Virus Infections, Infections, +6 more
- Locations
-
- Accellacare and McFarland Clinic Ames, Iowa, United States
- Johnson County ClinTrials, LLC Lenexa, Kansas, United States
- Rochester Clinical Research, Inc Rochester, New York, United States
- Accellacare of Cary - Cary Medical Group Cary, North Carolina, United States
Active, Not Recruiting
Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS
NCT04957485
- Conditions
- DNA Virus Infections, Infections, Poxviridae Infections, +2 more
- Locations
-
- Meridian Clinical Research Omaha, Nebraska, United States
- Aventiv Research Inc Columbus, Ohio, United States